Potential metal-related strategies for prevention and treatment of COVID-19.
Rare Metals
; 41(4): 1129-1141, 2022.
Article
in English
| MEDLINE | ID: covidwho-1635959
ABSTRACT
Abstract The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed severe threats to human health, public safety, and the global economy. Metal nutrient elements can directly or indirectly take part in human immune responses, and metal-related drugs have served as antiviral drugs and/or enzyme inhibitors for many years, providing potential solutions to the prevention and treatment of COVID-19. Metal-based drugs are currently under a variety of chemical structures and exhibit wide-range bioactivities, demonstrating irreplaceable advantages in pharmacology. This review is an intention to summarize recent progress in the prevention and treatment strategies against COVID-19 from the perspective of metal pharmacology. The current and potential utilization of metal-based drugs is briefly introduced. Specifically, metallohydrogels that have been shown to present superior antiviral activities are stressed in the paper as potential drugs for the treatment of COVID-19.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Journal:
Rare Metals
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS